Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 19.7
(-1.89%)
CNY 19.7
(-1.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 8.98 Billion CNY | 12.04% |
| 2022 | 8.02 Billion CNY | 8.6% |
| 2021 | 7.38 Billion CNY | 116.86% |
| 2020 | 3.4 Billion CNY | 37.07% |
| 2019 | 2.48 Billion CNY | 39.24% |
| 2018 | 1.78 Billion CNY | 184.28% |
| 2017 | 627.65 Million CNY | 500.91% |
| 2016 | 104.44 Million CNY | -3.24% |
| 2015 | 107.95 Million CNY | -29.25% |
| 2014 | 152.58 Million CNY | -5.84% |
| 2013 | 162.04 Million CNY | -28.1% |
| 2012 | 225.39 Million CNY | 45.57% |
| 2011 | 154.82 Million CNY | 102.8% |
| 2010 | 76.34 Million CNY | 155.93% |
| 2009 | 29.83 Million CNY | -2.31% |
| 2008 | 30.53 Million CNY | 304.31% |
| 2007 | 7.55 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 20.69 Billion CNY | 32.19% |
| 2024 Q1 | 12.6 Billion CNY | 40.3% |
| 2024 Q2 | 15.65 Billion CNY | 24.16% |
| 2023 Q4 | 8.98 Billion CNY | -13.67% |
| 2023 Q1 | 9.61 Billion CNY | 19.92% |
| 2023 FY | 8.98 Billion CNY | 12.04% |
| 2023 Q2 | 11.37 Billion CNY | 18.27% |
| 2023 Q3 | 10.4 Billion CNY | -8.5% |
| 2022 Q3 | 8.06 Billion CNY | 12.8% |
| 2022 Q2 | 7.15 Billion CNY | 7.95% |
| 2022 FY | 8.02 Billion CNY | 8.6% |
| 2022 Q1 | 6.62 Billion CNY | -10.3% |
| 2022 Q4 | 8.02 Billion CNY | -0.58% |
| 2021 FY | 7.38 Billion CNY | 116.86% |
| 2021 Q3 | 6.71 Billion CNY | 38.86% |
| 2021 Q4 | 7.38 Billion CNY | 9.94% |
| 2021 Q2 | 4.83 Billion CNY | 38.15% |
| 2021 Q1 | 3.5 Billion CNY | 2.83% |
| 2020 Q2 | 3.53 Billion CNY | -4.72% |
| 2020 Q4 | 3.4 Billion CNY | -14.75% |
| 2020 FY | 3.4 Billion CNY | 37.07% |
| 2020 Q1 | 3.7 Billion CNY | 49.14% |
| 2020 Q3 | 3.99 Billion CNY | 13.15% |
| 2019 Q2 | 1.89 Billion CNY | -9.43% |
| 2019 Q4 | 2.48 Billion CNY | -5.41% |
| 2019 FY | 2.48 Billion CNY | 39.24% |
| 2019 Q1 | 2.09 Billion CNY | 17.47% |
| 2019 Q3 | 2.62 Billion CNY | 38.36% |
| 2018 Q3 | 1.34 Billion CNY | 15.88% |
| 2018 FY | 1.78 Billion CNY | 184.28% |
| 2018 Q4 | 1.78 Billion CNY | 33.02% |
| 2018 Q2 | 1.15 Billion CNY | 37.81% |
| 2018 Q1 | 839.99 Million CNY | 33.83% |
| 2017 Q2 | 196.84 Million CNY | 83.46% |
| 2017 Q3 | 340.54 Million CNY | 73.0% |
| 2017 Q4 | 627.65 Million CNY | 84.31% |
| 2017 FY | 627.65 Million CNY | 500.91% |
| 2017 Q1 | 107.29 Million CNY | 2.72% |
| 2016 Q2 | 110.62 Million CNY | 0.03% |
| 2016 Q4 | 104.44 Million CNY | -10.32% |
| 2016 FY | 104.44 Million CNY | -3.24% |
| 2016 Q3 | 116.46 Million CNY | 5.28% |
| 2016 Q1 | 110.59 Million CNY | 2.45% |
| 2015 Q3 | 101.8 Million CNY | 0.48% |
| 2015 FY | 107.95 Million CNY | -29.25% |
| 2015 Q1 | 115.95 Million CNY | -24.01% |
| 2015 Q2 | 101.31 Million CNY | -12.62% |
| 2015 Q4 | 107.95 Million CNY | 6.04% |
| 2014 Q4 | 152.58 Million CNY | -9.51% |
| 2014 Q2 | 179.32 Million CNY | 9.14% |
| 2014 Q1 | 164.31 Million CNY | 1.4% |
| 2014 FY | 152.58 Million CNY | -5.84% |
| 2014 Q3 | 168.62 Million CNY | -5.97% |
| 2013 Q3 | 176.84 Million CNY | -3.94% |
| 2013 Q1 | 215.28 Million CNY | -4.48% |
| 2013 FY | 162.04 Million CNY | -28.1% |
| 2013 Q4 | 162.04 Million CNY | -8.36% |
| 2013 Q2 | 184.09 Million CNY | -14.49% |
| 2012 Q3 | 180.09 Million CNY | 2.08% |
| 2012 Q4 | 225.39 Million CNY | 25.15% |
| 2012 FY | 225.39 Million CNY | 45.57% |
| 2012 Q2 | 176.41 Million CNY | 8.06% |
| 2012 Q1 | 163.25 Million CNY | 5.44% |
| 2011 Q3 | 134.63 Million CNY | 2.33% |
| 2011 Q2 | 131.56 Million CNY | 66.98% |
| 2011 Q1 | 78.78 Million CNY | 3.2% |
| 2011 FY | 154.82 Million CNY | 102.8% |
| 2011 Q4 | 154.82 Million CNY | 15.0% |
| 2010 Q4 | 76.34 Million CNY | 150.76% |
| 2010 FY | 76.34 Million CNY | 155.93% |
| 2010 Q2 | 28.53 Million CNY | 0.0% |
| 2010 Q3 | 30.44 Million CNY | 6.69% |
| 2009 Q4 | 29.83 Million CNY | 0.0% |
| 2009 FY | 29.83 Million CNY | -2.31% |
| 2008 FY | 30.53 Million CNY | 304.31% |
| 2007 FY | 7.55 Million CNY | 0.0% |